CCR5 and coinfection: We found that a high copy number of CCL3L1, the gene encoding the most potent HIV suppressive ligand of CCR5, associated with a reduced risk of HIV seropositivity after controlling for HCV and HBV co-infection status as well as length of intravenous drug use (IVDU).